Biologic Therapy for Generalized Pustular Psoriasis
NCT06391996
·
clinicaltrials.gov ↗
COMPLETED
Status
65
Enrollment
OTHER
Sponsor class
Conditions
Generalized Pustular Psoriasis
Interventions
DRUG:
After exclusion of relevant contraindications, participants received subcutaneous ustekinumab/secukinumab therapy.
Sponsor
Chao Ji